BioNT ICO review, all information about token sale BioNT (BIONT) | ICORating
  1. Home
  2. ICO
  3. BioNT

BioNT

Drugs & Healthcare

Overview

The BioNT team develops global drug pricing platform.

Features

The services that will be offered include: - Single global drug pricing platform - Disease and epidemiology database - Drug forecasting platform - Integrated – drug pricing and forecasting system through Blockchain - Securities trading signals

Crowdsale

Token Sale
ICO start date 20 Aug 2017
ICO end date 22 Oct 2017
Token details
Ticker BIONT
Additional Token Emission No
Accepted Currencies

ETH

Token distribution

126 million tokens available for the crowd sale campaign. 14 million tokens, with a 6 month lock up, are reserved for Advanced Intelligence GmbH and founders team. Funds allocaton: Enhancement and, Commercialization Beta Pricing Platform, 10% Development, 55% Legal, 5% Team Allocation, 10% Global Sales and Marketing, 20%

Ratings

Type of ratings
Rating
Status
Risk score
Medium
Active

Team members

Name
Position
Score
Social
NA
NA
NA
NA

Funding Rounds

Rating Review and Analytics

Investment rating Info NA
Hype score Info Low
Risk score Info Medium
BioNT ICO Contacts
More on ICO

Ended

Start ICO 20 Aug 2017
End ICO 22 Oct 2017
Token BIONT
Whitepaper View
BioNT (BIONT) widget
Rating Get this widget
ICOs that might interest you

Status Ongoing
Hype score High
Risk score Medium
Investment rating Stable


Status Pending
Hype score High
Risk score Medium
Basic Review NA


Status Pending
Hype score High
Risk score NA
Basic Review NA


Status Pending
Hype score Medium
Risk score Medium
Basic Review NA